Hemophilia patient taking Altuviiio: David
Hemophilia patient taking Altuviiio: David
“Transitioning to ALTUVIIIO was very easy for me. Instead of infusing every 4 days, I infuse once a week.”
David
David
On ALTUVIIIO prophylaxis since June 2023.
On ALTUVIIIO prophylaxis since June 2023.

Hear from David

“I was diagnosed with hemophilia A at just 3 months old. Throughout my childhood, I longed to be a kid and take the stairs 2 (or even 3) at a time- an activity others didn't have to think twice about. But frequent ankle bleeds led me to walk with a cane at just 14 years old.

In college, I decided to pursue my passion for opera performance. Performing on stage is physically demanding. Because of the high-risk activities I engaged in, I was required to infuse multiple times a week.

After hearing about once-weekly ALTUVIIIO, I immediately asked my doctor about switching treatment. I was excited to learn that ALTUVIIIO prophylaxis was shown to have higher-for-longer factor levels in the near-normal to normal range (over 40%) for most of the week and a 48-hour half-life in adults-which meant I'd have to infuse only once a week.

Offstage, I use my voice for advocacy. I hope that people with hemophilia will work with their doctors to find the right treatment plan for them and their lifestyles, just like I did!"

David is a promotional speaker compensated by Sanofi and received free product through Sanofi's Patient Support Program.

“I was diagnosed with hemophilia A at just 3 months old. Throughout my childhood, I longed to be a kid and take the stairs 2 (or even 3) at a time- an activity others didn't have to think twice about. But frequent ankle bleeds led me to walk with a cane at just 14 years old.

In college, I decided to pursue my passion for opera performance. Performing on stage is physically demanding. Because of the high-risk activities I engaged in, I was required to infuse multiple times a week.

After hearing about once-weekly ALTUVIIIO, I immediately asked my doctor about switching treatment. I was excited to learn that ALTUVIIIO prophylaxis was shown to have higher-for-longer factor levels in the near-normal to normal range (over 40%) for most of the week and a 48-hour half-life in adults-which meant I'd have to infuse only once a week.

Offstage, I use my voice for advocacy. I hope that people with hemophilia will work with their doctors to find the right treatment plan for them and their lifestyles, just like I did!"

David is a promotional speaker compensated by Sanofi and received free product through Sanofi's Patient Support Program.

Hear from more patients

Hemophilia patient Paxton and his caregiver Jenny
Paxton and Jenny
Jenny is Paxton’s mom and caregiver. Paxton is on ALTUVIIIO prophylaxis
Hemophilia patient taking Altuviiio: Joey
Joey
A patient who has been on ALTUVIIIO prophylaxis since May 2023
Hemophilia patient AJ taking Altuviiio and his caregiver Bonnie
AJ and Bonnie
Bonnie is AJ’s mom and caregiver. AJ is on ALTUVIIIO prophylaxis
Join our Peer Program
Are you currently on ALTUVIIIO? Do you want to share your experience with others? This program may be perfect for you.
Are you currently on ALTUVIIIO? Do you want to share your experience with others? This program may be perfect for you.